Format

Send to

Choose Destination
See comment in PubMed Commons below
Hematol Oncol Clin North Am. 2006 Jun;20(3):567-84.

Cancer immunotherapy and preclinical studies: why we are not wasting our time with animal experiments.

Author information

1
Department of Pathology, The University of Chicago, IL 60637, USA. hszz@midway.uchicago.edu

Abstract

Experimental research on the immune response to transplanted tumors has led to pioneering discoveries that laid many of the foundations for the current field of immunology. Experimental research in oncology has proven that murine and human tumors have antigens that are truly cancer specific. This article discusses research investigating how can antigens on cancer cells be used to help eradicate cancer.

PMID:
16762725
DOI:
10.1016/j.hoc.2006.03.001
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center